SUVRETTA CAPITAL MANAGEMENT, LLC → Faeth Therapeutics, Inc. FTH

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-09-30

DTC 3.63

2,067,445 shares short · +56.8% vs prior

Other 13D/G Filings on Faeth Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13G	S2G Investments, LLC	—	—	view →
2023-05-23	SC	Apeiron Investment Group Ltd.	—	—	view →
2022-11-21	SC	Apeiron Investment Group Ltd.	—	—	view →

Other Filings by SUVRETTA CAPITAL MANAGEMENT, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-21	SCHEDULE 13D/A	Veradermics, Incorporated	8.80%	3,718,970	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →